4
Changes in Ownership
Avantor, Inc. Filed Acc 0001722482-21-000025
EVP, Biopharma Production sold 378,580 shares at an average $30.06 ($11,381,196)
- EVP, Biopharma Production acquired 378,580 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Brophy Gerard · EVP, Biopharma Production
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-11 | Exercise or conversion : show line 1 in the form | +216,332 | $23.20 | $5,018,902 | 394,847 | D |
| 2021-01-11 | Sale : show line 2 in the form | −216,332 | $30.08 | $6,507,267 | 178,515 | D |
| 2021-01-11 | Exercise or conversion : show line 3 in the form | +162,248 | $23.20 | $3,764,154 | 340,763 | D |
| 2021-01-11 | Sale : show line 4 in the form | −162,248 | $30.04 | $4,873,930 | 178,515 | D |
| Open-market sales · 378,580 sh · avg $30.06 · $11,381,196 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-11 | Exercise or conversion : show line 5 in the form Stock Options (Right to Buy) | −162,248 | 162,250 | D |
Loading xslF345X03/wf-form4_161057768826138.xml…